Readmission to Hospital

🩺What is Readmission to Hospital?

The LACE Index was developed by Dr. Carl van Walraven and colleagues in 2010 and published in the Canadian Medical Association Journal (CMAJ). It was derived from a cohort of 4,812 medical and surgical patients discharged from 11 teaching and community hospitals in Ontario, Canada. The score uses four components: L — Length of stay (categorized into 6 levels from 1 to ≥14 days, with weighted points 1-7), A — Acuity of the admission (3 points if admitted through the ED or as an urgent case, 0 otherwise), C — Comorbidity as measured by the Charlson Comorbidity Index (converted to a 0-5 point scale), and E — Emergency department visits in the 6 months prior to admission (0-4 visits, weighted 0-4 points). The total score ranges from 0 to 19. The LACE Index has been externally validated in multiple healthcare systems and demonstrates reasonable discriminative ability for 30-day readmission (c-statistic 0.68-0.78). It is widely used in hospital quality improvement programs, transition of care initiatives, and as a case-mix adjustment tool for readmission benchmarking.

📊Clinical Assessment & Risk Scoring

Healthcare professionals use these validated clinical calculators, diagnostic scales, and risk scoring systems to assess the severity, prognosis, or therapeutic dosing requirements for Readmission to Hospital:

• LACE Index — Readmission Risk

  The LACE Index predicts the risk of unplanned 30-day hospital readmission or death. It combines Length of stay, Acuity of admission, Comorbidity (Charlson), and Emergency department visits in the prior 6 months into a single validated risk score.

• HOSPITAL Score — Avoidable Readmission

  The HOSPITAL score predicts the risk of 30-day potentially avoidable hospital readmissions using 8 clinical variables. It was designed to identify patients at high risk for readmissions that might be prevented better transitional care.

🧬Diagnostic Logic & Scoring Breakdown

LOS: 1 day=1, 2=2, 3=3, 4-6=4, 7-13=5, ≥14=7. Acuity: 3 if admitted from ED or urgent, else 0. Charlson: 0=0, 1=1, 2=2, 3=3, ≥4=5. ED visits (past 6 months): 0=0, 1=1, 2=2, 3=3, ≥4=4.

📢Clinical Significance & Implications

Hospital readmissions are a major quality metric and cost driver in healthcare systems worldwide. The LACE Index is one of the most widely validated readmission prediction tools and is used by hospitals for risk stratification, resource allocation for transitional care programs, and as a risk-adjustment variable in readmission benchmarking. The index has been embedded in electronic health records and discharge planning workflows across Canada, the United States, and Europe. Studies have shown that LACE-guided transitional care interventions can reduce 30-day readmission rates by 15-30% in high-risk populations.

💡 Clinical Assessment Scenario Example

A 65-year-old man with diabetes (CCI=2), admitted from the ED for cellulitis, LOS 8 days, with 2 ED visits in the prior 6 months. L=5 (LOS 7-13), A=3 (ED admission), C=2 (CCI=2), E=2 (2 visits). Total LACE = 5+3+2+2 = 12/19 (high risk). Recommended: intensive transitional care with 7-day follow-up.

⚠️Clinical Assessment Pitfalls

• ❌ Mistake: Counting planned ED visits (e.g., scheduled IV therapy) in the ED visits component

  ✅ Correction: Only count unplanned ED visits in the 6 months prior to admission. Scheduled or planned visits should not be included.

• ❌ Mistake: Using total hospital days including days in the ED observation unit

  ✅ Correction: LOS should only include days after admission to an inpatient bed. Observation unit or ED holding time should not be counted.

• ❌ Mistake: Using admission hemoglobin instead of discharge hemoglobin

  ✅ Correction: The HOSPITAL score uses the lowest hemoglobin in the 24 hours before discharge, not the admission value.

• ❌ Mistake: Under-counting prior admissions

  ✅ Correction: Include all unplanned hospital admissions in the 12 months prior to the index admission, including transfers from other facilities.

🚑When to Seek Medical Attention

This reference supports clinical assessment of Readmission to Hospital; it does not replace urgent evaluation. Seek prompt in-person medical care if symptoms are severe, rapidly worsening, or life-threatening, or if you are unsure about a diagnosis or treatment plan. Patients should always consult their physician before starting or changing any therapy.

❓Frequently Asked Questions

📚Evidence-Based References